Logo for Bioatla Inc

Bioatla Investor Relations Material

Latest events

Logo for Bioatla Inc

Q2 2024

Bioatla
Logo for Bioatla

Q2 2024

8 Aug, 2024
Logo for Bioatla

Q1 2024

14 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Bioatla Inc

Access all reports
Bioatla Inc is a clinical-stage biopharmaceutical company specializing in the development of novel monoclonal antibody and cell-based therapeutics for the treatment of solid tumor cancers. Utilizing its proprietary Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO) platforms, Bioatla is focused on creating therapies with improved selectivity for the tumor microenvironment, potentially enhancing safety and therapeutic efficacy. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.